adUnits.push({
code: ‘Rpp_mundo_actualidad_Nota_Interna1’,
mediaTypes: {
banner: {
sizes: (navigator.userAgent.match(/iPhone|android|iPod/i)) ? [[300, 250], [320, 460], [320, 480], [320, 50], [300, 100], [320, 100]] : [[300, 250], [320, 460], [320, 480], [320, 50], [300, 100], [320, 100], [635, 90]]
}
},
bids: [{
bidder: ‘appnexus’,
params: {
placementId: ‘14149971’
}
},{
bidder: ‘rubicon’,
params: {
accountId: ‘19264’,
siteId: ‘314342’,
zoneId: ‘1604128’
}
},{
bidder: ‘amx’,
params: {
tagId: ‘MTUybWVkaWEuY29t’
}
},{
bidder: ‘oftmedia’,
params: {
placementId: navigator.userAgent.match(/iPhone|android|iPod/i) ? ‘22617692’: ‘22617693’
}
}]
});
On Monday, the GAVI Vaccine Foundation announced an agreement with US pharmaceutical company Moderna to offer 100 million doses of the vaccine. antiviral vaccines adapted to the new options for low-income countries in 2023.
The agreement “is a big step forward towards equal access to help the program COVACS adjust their stocks in line with demand and ensure that low-income countries have access to appropriate vaccines,” said GAVI CEO Seth Berkeley.
The agreement also implies the cancellation of deliveries still pending for 2022 to offer vaccine more adapted to evolution pandemic.
The COVAX program, which World Health Organization (WHO), According to GAVI, it has distributed 1.8 billion anti-covid vaccines (186 million Moderna) to 146 countries, representing “the largest and fastest public health distribution in history.”
These efforts, the organization emphasizes, have enabled 92 low-income countries, many of them in Africa, as well as Asia and Latin America, to protect an average of 50% of their population from COVID-19.
covid antibodies
antibodies against the SARS-CoV-2 virus that causes COVID-19remain at least 20 months after the disease, as shown by a study conducted with a 20-month follow-up of 247 healthcare workers in Catalonia (north) who were infected with COVID-19 at the beginning of the pandemic.
A study co-led by the Barcelona Institute for Global Health (ISGlobal), the Catalan Institute of Public Health (ICS) and the IDIAP Jordi Gol (IDIAP JG), in collaboration with the private foundation Daniel Bravo Andreu (FPDBA). obesity, age and smoking have also been shown to be associated with lower response antibodies.
EFE
Source: RPP
I’m Liza Grey, an experienced news writer and author at the Buna Times. I specialize in writing about economic issues, with a focus on uncovering stories that have a positive impact on society. With over seven years of experience in the news industry, I am highly knowledgeable about current events and the ways in which they affect our daily lives.